Published in Diabetologia on October 10, 2007
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag (2009) 1.24
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol (2013) 1.15
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. Arthritis Rheum (2012) 1.00
Uric acid and antioxidant effects of wine. Croat Med J (2010) 0.85
Determinants of vascular function in patients with chronic gout. J Clin Hypertens (Greenwich) (2010) 0.80
Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats. J Pharmacol Exp Ther (2010) 0.78
The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose? Open Heart (2014) 0.78
Serum Uric Acid Is Associated with Erectile Dysfunction: A Population-Based Cross-Sectional Study in Chinese Men. Sci Rep (2017) 0.75
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens (1998) 4.94
Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet (1994) 4.90
Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J Cell Biol (2001) 3.99
The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol (2000) 3.43
Core content of a course in clinical pharmacology. Br J Clin Pharmacol (1997) 2.99
Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) (1983) 2.90
Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens (1993) 2.59
Ultrasonic hydrophone based on short in-fiber bragg gratings. Appl Opt (1998) 2.35
Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol (1999) 2.35
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31
Are medical students adequately trained to prescribe at the point of graduation? Views of first year foundation doctors. Scott Med J (2006) 2.29
Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin. Diabet Med (2007) 2.21
The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci (Lond) (1993) 2.18
Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12
Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol (2001) 1.97
External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med (2013) 1.90
Screening for human immunodeficiency virus: a survey of British clinical pharmacology units. Br J Clin Pharmacol (1993) 1.85
Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM (2000) 1.84
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation (1999) 1.79
Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol (2001) 1.77
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond) (2003) 1.66
Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest (1997) 1.65
Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation (1998) 1.61
L-NMMA increases blood pressure in man. Lancet (1993) 1.60
Contribution of parental blood pressures to association between low birth weight and adult high blood pressure: cross sectional study. BMJ (1998) 1.60
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine (2005) 1.59
Developing a core curriculum in clinical pharmacology and therapeutics: a Delphi study. Br J Clin Pharmacol (1997) 1.58
Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J Cell Sci (2001) 1.52
Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health. Cardiovasc Res (2002) 1.51
Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabet Med (2014) 1.49
Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres. J Antimicrob Chemother (2006) 1.49
Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens (1998) 1.48
Ambulatory blood pressure monitoring: is it necessary for the routine assessment of hypertension in people with diabetes? Diabet Med (2002) 1.47
Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation (1996) 1.47
32-km distributed temperature sensor based on Brillouin loss in an optical fiber. Opt Lett (1993) 1.46
Aortic pulse-wave velocity. Lancet (1999) 1.45
Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man. Cardiovasc Res (2000) 1.43
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol (2007) 1.38
Transversal and longitudinal images from the retina of the living eye using low coherence reflectometry. J Biomed Opt (1998) 1.36
Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology (2006) 1.34
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation (2001) 1.32
Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol (1989) 1.32
Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation (1995) 1.31
Blood glucose monitors: a laboratory and patient assessment. Br Med J (1980) 1.30
Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide. Clin Sci (Lond) (1997) 1.27
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart (2005) 1.26
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med (2002) 1.24
Direct measurement of intracellular pH changes in Xenopus eggs at fertilization and cleavage. J Cell Biol (1981) 1.23
Assessment of the under-reporting of diabetes in hospital admission data: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabet Med (2011) 1.23
Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension (1999) 1.21
Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol (1998) 1.21
Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score. Diabet Med (2006) 1.20
Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab (1995) 1.19
Measurement of plasma angiotensin II. Clin Sci (Lond) (1985) 1.19
31P NMR reveals increased intracellular pH after fertilization in Xenopus eggs. Proc Natl Acad Sci U S A (1981) 1.18
An electrical block is required to prevent polyspermy in eggs fertilized by natural mating of Xenopus laevis. Dev Biol (1982) 1.18
Simultaneous en-face imaging of two layers in the human retina by low-coherence reflectometry. Opt Lett (1997) 1.17
Pulse transit time measured from the ECG: an unreliable marker of beat-to-beat blood pressure. J Appl Physiol (1985) (2005) 1.16
Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clin Endocrinol (Oxf) (1996) 1.16
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem Biophys Res Commun (2000) 1.16
Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci (1999) 1.16
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther (1996) 1.12
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia (2012) 1.11
Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation (1998) 1.11
Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation (1996) 1.11
Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. J Biol Chem (1994) 1.11
Scottish Medicines Consortium: an overview of rapid new drug assessment in Scotland. Scott Med J (2007) 1.08
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol (2001) 1.08
Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens (2000) 1.07
Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man. J Physiol (2001) 1.05
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut (2003) 1.04
Co-proxamol overdose is associated with a 10-fold excess mortality compared with other paracetamol combination analgesics. Br J Clin Pharmacol (2005) 1.03
Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation (2000) 1.03
Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries. Br J Pharmacol (1997) 1.03
Fertilization potential and electrical properties of the Xenopus laevis egg. Dev Biol (1985) 1.02
Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol (1998) 1.02
Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology (2001) 1.01
Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart (2004) 1.01
Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability. Br J Clin Pharmacol (1997) 1.01
Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach. Bull Math Biol (2002) 1.00
An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost (1997) 1.00
Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. QJM (2009) 1.00
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation (1998) 0.99
Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation (1991) 0.99
Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension (1998) 0.99
Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans. J Cardiovasc Pharmacol (1995) 0.98
Coherence imaging by use of a Newton rings sampling function. Opt Lett (1996) 0.98
S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. Br J Pharmacol (2000) 0.97
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Diabetes Care (2001) 0.96
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation (1996) 0.95
Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation (2001) 0.95